Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

Lignende værker

• Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)
  af: Fenaux, Pierre, et al.
  Udgivet: (2017)
• The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q)
  af: Sekeres, Mikkael A., et al.
  Udgivet: (2018)
• Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes
  af: Giagounidis, Aristoteles, et al.
  Udgivet: (2008)
• Impaired formation of erythroblastic islands is associated with erythroid failure and poor prognosis in a significant proportion of patients with myelodysplastic syndromes
  af: Buesche, Guntram, et al.
  Udgivet: (2016)
• Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide
  af: Göhring, Gudrun, et al.
  Udgivet: (2011)